Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 24, 2020
Reporting Period: Events occurring on November 24, 2020.
The filing discloses the entry into a material definitive agreement for a future equity offering and the execution of an unregistered sale of equity securities.
Key Financial Metrics and Capital Transactions
- Equity Line of Credit (Item 1.01): Entered into a Purchase Agreement with Lincoln Park Capital Fund, LLC allowing the Company to sell up to $47,000,000 of Class A common stock over a 36-month term.
- Commitment Fee: Issued 425,725 shares of Common Stock to Lincoln Park as a commitment fee (no cash proceeds received).
- Initial Purchase Obligation: Lincoln Park is obligated to make an initial purchase of $2,000,000 upon satisfaction of conditions.
- Unregistered Sale (Item 3.02): Sold 625,000 shares of Class A common stock to MacAndrews & Forbes Group LLC at $1.60 per share, raising $1,000,000 in cash proceeds.
- Outstanding Shares: Approximately 73,880,351 shares outstanding immediately prior to the execution of the Purchase Agreement.
- Revenue/Profit/Cash Flow: The filing text does not provide specific revenue, profit, cash flow, or margin data for the period.
Material Changes and Transaction Terms
Equity Line Mechanics:
- Purchase Price: The lower of the lowest sale price on the purchase date or the average of the three lowest closing prices during the 10 trading days prior.
- Volume Limits: Regular purchases are capped at 250,000 shares (increasing to 275,000 or 300,000 based on stock price thresholds). Maximum single purchase is $2,000,000.
- Accelerated Purchases: The Company may direct additional purchases up to 300% of the regular purchase amount, subject to trading volume limits.
- Ownership Caps: Lincoln Park cannot exceed 9.99% beneficial ownership. The total issuance under the agreement is capped at 19.99% of pre-transaction outstanding shares (approx. 14,768,682 shares) unless stockholder approval is obtained.
Use of Proceeds: The Company expects to use proceeds from the Offering for general corporate purposes and working capital.
Guidance, Risks, and Contingencies
- Market Conditions: Actual proceeds and sales volume depend on market conditions, trading prices, and the Company's discretion regarding funding sources.
- Dilution Risk: The issuance of Commitment Shares and potential future sales under the Purchase Agreement will result in dilution to existing shareholders.
- Short Selling Restrictions: Lincoln Park has covenanted not to engage in short selling or hedging of the Common Stock.
- Termination: The Company may terminate the Purchase Agreement at any time without fee or penalty.
- Exclusivity: The Company may not enter into another "equity line" or similar transaction, though it retains the ability to raise capital from other sources.
Investor Verification Checklist
- Verify the effectiveness of the registration statement required by November 30, 2020, to enable the $47 million offering.
- Monitor the Company's stock price relative to the $4.00 and $5.00 thresholds that increase the Regular Purchase Share Limit.
- Review the impact of the 425,725 Commitment Shares on immediate dilution.
- Confirm whether the Company exercises the right to sell shares under the new agreement or relies on other funding sources.
- Check for any subsequent filings regarding stockholder approval if the Company intends to exceed the 19.99% Exchange Cap.